I. Delil Et Al. , "Vitreous and serum VEGF levels after intravitreal injection of bevacizumab ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy," European Association for Vision and Eye Research Conference , 2016
Delil, I. Et Al. 2016. Vitreous and serum VEGF levels after intravitreal injection of bevacizumab ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy. European Association for Vision and Eye Research Conference .
Delil, I., Cekic, O., & HAKLAR, G., (2016). Vitreous and serum VEGF levels after intravitreal injection of bevacizumab ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy . European Association for Vision and Eye Research Conference
Delil, Isil, Orhan Cekic, And GONCAGÜL HAKLAR. "Vitreous and serum VEGF levels after intravitreal injection of bevacizumab ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy," European Association for Vision and Eye Research Conference, 2016
Delil, Isil Et Al. "Vitreous and serum VEGF levels after intravitreal injection of bevacizumab ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy." European Association for Vision and Eye Research Conference , 2016
Delil, I. Cekic, O. And HAKLAR, G. (2016) . "Vitreous and serum VEGF levels after intravitreal injection of bevacizumab ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy." European Association for Vision and Eye Research Conference .
@conferencepaper{conferencepaper, author={Isil Delil Et Al. }, title={Vitreous and serum VEGF levels after intravitreal injection of bevacizumab ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy}, congress name={European Association for Vision and Eye Research Conference}, city={}, country={}, year={2016}}